Quantcast

Latest Venrock Stories

2014-08-25 23:08:38

Funds Focused on Closing the Loop Between Advocate Marketing & ROI SAN FRANCISCO, CA (PRWEB) August 25, 2014 Dynamic Signal, industry leader in employee advocacy solutions, announced that it has closed a USD $12M million Series C financing round led by new lead investor Rembrandt Venture Partners as well as existing investors, Venrock, Trinity Ventures, Time Warner Ventures and Cox Enterprises, who continue to see value in the company based on feedback from clients and prospects, and...

2014-06-17 08:35:05

Company seeks to greatly simplify and slash costs of Wide Area Networks (WAN) LOS ALTOS, Calif., Jun 17, 2014 /PRNewswire/ -- VeloCloud Networks, Inc., a pioneer in Cloud-Delivered WAN, today announced it has raised $21 million in funding led by leading venture capital firms New Enterprise Associates (NEA) and Venrock as well as incubator firm, The Fabric. VeloCloud dramatically simplifies the WAN by delivering virtualized services from the cloud to branch offices and mobile users...

2014-05-22 08:35:51

ICONIQ Capital leads newest round of funding; total raised to date nears $65 million NEW YORK, May 22, 2014 /PRNewswire/ -- Smartling, Inc. today announced it has closed a $25 million series D round of funding, led by ICONIQ Capital, a global multi-family office and merchant bank based in San Francisco. Smartling provides a software platform that helps companies to better compete globally by translating and managing their multilingual Web, mobile and business document content....

2014-04-22 12:30:18

- Proceeds will Further Strengthen Avalanche's Proprietary BioFactoryTM Platform and Advance Clinical Program in Wet Age-Related Macular Degeneration - MENLO PARK, Calif., April 22, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc, a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the successful completion of a $55 million Series B financing. New investors were led by Venrock, and...

2014-01-13 16:25:48

Juno CEO Hans Bishop to Address JP Morgan's 32nd Annual Healthcare Conference SEATTLE, Jan. 13, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, a new biotechnology company focused on bringing forward novel immunotherapies for cancer, announced today an expanded Series A including Bezos Expeditions, the personal investment company of Jeff Bezos, and leading venture capital firm Venrock. The total Series A will exceed $145M. (Logo:...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related